Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1848 2
1939 2
1947 2
1948 3
1950 5
1951 8
1952 15
1953 16
1954 10
1955 4
1956 1
1957 4
1958 1
1959 2
1960 6
1961 3
1962 4
1963 7
1964 7
1965 11
1966 16
1967 9
1968 11
1969 20
1970 12
1971 17
1972 21
1973 20
1974 13
1975 16
1976 11
1977 13
1978 11
1979 12
1980 3
1981 10
1982 10
1983 13
1984 20
1985 15
1986 14
1987 9
1988 19
1989 17
1990 19
1991 18
1992 17
1993 11
1994 10
1995 18
1996 15
1997 18
1998 20
1999 22
2000 21
2001 19
2002 19
2003 13
2004 10
2005 11
2006 14
2007 27
2008 33
2009 25
2010 30
2011 30
2012 32
2013 26
2014 22
2015 21
2016 24
2017 31
2018 28
2019 13
2020 15
2021 26
2022 13
2023 29
2024 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,099 results

Results by year

Filters applied: . Clear all
Page 1
Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots-A new collection method for remote settings.
Huber H, Blennow K, Zetterberg H, Boada M, Jeromin A, Weninger H, Nuñez-Llaves R, Aguilera N, Ramis M, Simrén J, Nilsson J, Lantero-Rodriguez J, Orellana A, García-Gutiérrez F, Morató X, Ashton NJ, Montoliu-Gaya L. Huber H, et al. Alzheimers Dement. 2024 Apr;20(4):2340-2352. doi: 10.1002/alz.13697. Epub 2024 Jan 29. Alzheimers Dement. 2024. PMID: 38284555 Free PMC article.
Efficacy and safety of antenatal steroids.
Kemp MW, Jobe AH, Usuda H, Nathanielsz PW, Li C, Kuo A, Huber HF, Clarke GD, Saito M, Newnham JP, Stock SJ. Kemp MW, et al. Among authors: huber hf. Am J Physiol Regul Integr Comp Physiol. 2018 Oct 1;315(4):R825-R839. doi: 10.1152/ajpregu.00193.2017. Epub 2018 Apr 11. Am J Physiol Regul Integr Comp Physiol. 2018. PMID: 29641233 Free article. Review.
End Point Surrogacy in First-Line Chronic Lymphocytic Leukemia.
Simon F, Ligtvoet R, Robrecht S, Cramer P, Kutsch N, Fürstenau M, Goede V, von Tresckow J, Langerbeins P, Fink AM, Huber H, Tausch E, Schneider C, Wendtner CM, Ritgen M, Dreyling M, Müller L, Jacobasch L, Heinz WJ, Vehling-Kaiser U, Sivcheva L, Böttcher S, Dreger P, Illmer T, Gregor M, Staber PB, Stilgenbauer S, Niemann CU, Kater AP, Fischer K, Eichhorst B, Hallek M, Al-Sawaf O. Simon F, et al. Among authors: huber h. J Clin Oncol. 2024 Aug 23:JCO2401192. doi: 10.1200/JCO.24.01192. Online ahead of print. J Clin Oncol. 2024. PMID: 39213466
Recombinant allergens: what does the future hold?
Valenta R, Niespodziana K, Focke-Tejkl M, Marth K, Huber H, Neubauer A, Niederberger V. Valenta R, et al. Among authors: huber h. J Allergy Clin Immunol. 2011 Apr;127(4):860-4. doi: 10.1016/j.jaci.2011.02.016. J Allergy Clin Immunol. 2011. PMID: 21458656 Review.
Reported methodological quality of split-mouth studies.
Lesaffre E, Garcia Zattera MJ, Redmond C, Huber H, Needleman I; ISCB Subcommittee on Dentistry. Lesaffre E, et al. Among authors: huber h. J Clin Periodontol. 2007 Sep;34(9):756-61. doi: 10.1111/j.1600-051X.2007.01118.x. J Clin Periodontol. 2007. PMID: 17716311 Review.
Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia.
Huber H, Edenhofer S, von Tresckow J, Robrecht S, Zhang C, Tausch E, Schneider C, Bloehdorn J, Fürstenau M, Dreger P, Ritgen M, Illmer T, Illert AL, Dürig J, Böttcher S, Niemann CU, Kneba M, Fink AM, Fischer K, Döhner H, Hallek M, Eichhorst B, Stilgenbauer S. Huber H, et al. Blood. 2022 Mar 3;139(9):1318-1329. doi: 10.1182/blood.2021013208. Blood. 2022. PMID: 35108374 Free article. Clinical Trial.
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
Krassnig S, Leber SL, Orthmann A, Golob-Schwarzl N, Huber HJ, Wohlrab C, Skofler C, Pennauer M, Raicht A, Birkl-Toeglhofer AM, Naumann M, Mahdy-Ali K, von Campe G, Leoni M, Alcaniz J, Hoffmann J, Wälchli T, Weis S, Benesch M, Haybaeck J. Krassnig S, et al. Among authors: huber hj. J Neurooncol. 2023 Oct;165(1):91-100. doi: 10.1007/s11060-023-04451-y. Epub 2023 Oct 31. J Neurooncol. 2023. PMID: 37907716 Free PMC article.
Treatment of small cell lung cancer patients.
Zöchbauer-Müller S, Pirker R, Huber H. Zöchbauer-Müller S, et al. Among authors: huber h. Ann Oncol. 1999;10 Suppl 6:83-91. doi: 10.1023/a:1008333713858. Ann Oncol. 1999. PMID: 10676558 Review.
1,099 results